![XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis – topic of research paper in Clinical medicine. Download XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis – topic of research paper in Clinical medicine. Download](https://cyberleninka.org/viewer_images/326523/f/1.png)
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis – topic of research paper in Clinical medicine. Download
![Amazon.com: Vasofe Abstract Large Shaggy Area Rug Modern Indoor Fluffy Rugs, Ultra Soft Baby Nursery Rugs for Bedroom Living Room Home,Non-Slip Boys Kids Girls Floor Carpet 5x8 Feet Camel : Home & Amazon.com: Vasofe Abstract Large Shaggy Area Rug Modern Indoor Fluffy Rugs, Ultra Soft Baby Nursery Rugs for Bedroom Living Room Home,Non-Slip Boys Kids Girls Floor Carpet 5x8 Feet Camel : Home &](https://m.media-amazon.com/images/I/81LvKwkP2hL.jpg)
Amazon.com: Vasofe Abstract Large Shaggy Area Rug Modern Indoor Fluffy Rugs, Ultra Soft Baby Nursery Rugs for Bedroom Living Room Home,Non-Slip Boys Kids Girls Floor Carpet 5x8 Feet Camel : Home &
![Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3a1819d84aae621048b39b1dd2a68219800faf2/7-Table3-1.png)
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar
![Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3a1819d84aae621048b39b1dd2a68219800faf2/3-Figure1-1.png)
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. | Semantic Scholar
![The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis - Mouhand F. H. Mohamed, Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis - Mouhand F. H. Mohamed, Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina](https://journals.sagepub.com/cms/10.1177/1076029620940046/asset/images/large/10.1177_1076029620940046-fig2.jpeg)
The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis - Mouhand F. H. Mohamed, Mohamad Nabil ElShafei, Mohamed Badie Ahmed, Lina
![Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes - Research and Practice in Thrombosis and Haemostasis Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/asset/344c2629-4eeb-45fa-b841-5f84bf98bd37/rth212604-fig-0001-m.jpg)
Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes - Research and Practice in Thrombosis and Haemostasis
![Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies - Research and Practice in Thrombosis and Haemostasis Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/attachment/ace39b55-a099-4246-9470-8c9a821ad999/rth212489-fig-0001-m_lrg.jpg)
Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies - Research and Practice in Thrombosis and Haemostasis
![A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts Prof. - ppt download A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts Prof. - ppt download](https://slideplayer.com/15941342/88/images/slide_1.jpg)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts Prof. - ppt download
![Validation of the VTE‐BLEED score's long‐term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry - Journal of Thrombosis and Haemostasis Validation of the VTE‐BLEED score's long‐term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry - Journal of Thrombosis and Haemostasis](https://www.jthjournal.org/cms/attachment/da7f70ee-d5f1-4cea-90fa-b3db4e4e8db9/jth14691-fig-0001-m_lrg.jpg)
Validation of the VTE‐BLEED score's long‐term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry - Journal of Thrombosis and Haemostasis
![Baseline demographics and clinical characteristics of patients in the... | Download Scientific Diagram Baseline demographics and clinical characteristics of patients in the... | Download Scientific Diagram](https://www.researchgate.net/publication/324467494/figure/tbl1/AS:775711606439937@1561955467747/Baseline-demographics-and-clinical-characteristics-of-patients-in-the-XALIA-treatment.png)
Baseline demographics and clinical characteristics of patients in the... | Download Scientific Diagram
![Αγανάκτησε και παραιτήθηκε η Διευθύντρια της Παθολογικής στο Νοσοκομείο Ρεθύμνου – Τα χάλια του ΕΣΥ που καταγγέλλει - grafoyme.gr Αγανάκτησε και παραιτήθηκε η Διευθύντρια της Παθολογικής στο Νοσοκομείο Ρεθύμνου – Τα χάλια του ΕΣΥ που καταγγέλλει - grafoyme.gr](https://i0.wp.com/grafoyme.gr/wp-content/uploads/2023/01/nosokomeio.jpg?fit=1024%2C563&ssl=1)
Αγανάκτησε και παραιτήθηκε η Διευθύντρια της Παθολογικής στο Νοσοκομείο Ρεθύμνου – Τα χάλια του ΕΣΥ που καταγγέλλει - grafoyme.gr
![For U.S. Media Only: Janssen Announces 25 Presentations at Upcoming ESC Congress 2016, Including New Clinical and Real-World Research on XARELTO® and Latest Findings from REVISIT-US | Johnson & Johnson For U.S. Media Only: Janssen Announces 25 Presentations at Upcoming ESC Congress 2016, Including New Clinical and Real-World Research on XARELTO® and Latest Findings from REVISIT-US | Johnson & Johnson](https://jnj-content-lab.brightspotcdn.com/dims4/default/96fa3e0/2147483647/strip/true/crop/785x1294+0+0/resize/785x1294!/quality/90/?url=http%3A%2F%2Fjnj-brightspot.s3.amazonaws.com%2Fb7%2F48%2Fa78180a14684a7ef2d7a712819a0%2Fjnj.png)
For U.S. Media Only: Janssen Announces 25 Presentations at Upcoming ESC Congress 2016, Including New Clinical and Real-World Research on XARELTO® and Latest Findings from REVISIT-US | Johnson & Johnson
![PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis](https://i1.rgstatic.net/publication/328404687_Healthcare_resource_use_in_XALIA_A_subgroup_analysis_of_a_non-interventional_study_of_rivaroxaban_versus_standard_anticoagulation_for_deep_vein_thrombosis/links/5e6403ed92851c7ce04ef02c/largepreview.png)
PDF) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis
![Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study - ScienceDirect Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952922002440-grabsf1.jpg)